Burleson R L, Jones D B, Yenikomshian A M, Cornwall C, DeVoe C, DeRito J
Arch Surg. 1978 Jun;113(6):688-92. doi: 10.1001/archsurg.1978.01370180030003.
Eighty-six human kidneys have been preserved by cryoperfusion with an albumin-based perfusate for five to 50 hours prior to transplantation. Sixty-three of the kidneys were transplanted. The overall immediate function rate was 72% and was 100% (34/34) for kidneys with no warm ischemic damage transplanted into recipients without hypotension or prior sensitivity. The overall actuarial one-month kidney survival rate was 87%, the three-month survival was 73%, and the one-year survival rate was 65%. No kidney was discarded because of poor perfusion. Perfusion data, including flow, dastolic pressure, perfusion time, and lactate concentration were not predictive of immediate renal function. Light, electron, and immunofluorescence microscopic study of biopsy specimens showed no evidence of perfusion or immunologic damage to the kidneys. Perfusion of transplantable kidneys with albumin provides reliable preservation for up to 50 hours without producing either structural or immunologic damage to the organ.
86个供体肾脏在移植前用基于白蛋白的灌注液进行低温灌注保存5至50小时。其中63个肾脏进行了移植。总体即时功能恢复率为72%,对于移植到无低血压或既往无致敏受者体内且无热缺血损伤的肾脏,即时功能恢复率为100%(34/34)。总体精算1个月肾脏存活率为87%,3个月存活率为73%,1年存活率为65%。没有肾脏因灌注不良而被丢弃。包括流量、舒张压、灌注时间和乳酸浓度在内的灌注数据不能预测即时肾功能。活检标本的光镜、电镜和免疫荧光显微镜研究显示,没有证据表明肾脏存在灌注或免疫损伤。用白蛋白对可移植肾脏进行灌注可提供长达50小时的可靠保存,且不会对器官造成结构或免疫损伤。